For example, for breast cancer, international guidelines now classify genes as high (BRCA1/2), moderate (BARD1), and low penetrance (BRIP1) and favor mastectomy for high penetrance but surveillance with magnetic resonance imaging and mammograms for others [56]. This evidence concerns the gene BARD1 and breast cancer.